3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
19
Urinary Bladder Neoplasms
4
Neoplasms
2
Urothelial Bladder Cancer
1
Urologic Neoplasms
1
Urinary Bladder Diseases
1
Stomach Neoplasms
1
Recurrence
1
Prostate cancer, familial
1
Parotid Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Lung Neoplasms
1
Genetic Predisposition to Disease
1
Driving Under the Influence
1
Disease
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Cystectomy
2
tislelizumab
1
relatlimab
1
enzalutamide
1
durvalumab
1
Urinary Diversion
1
Radiosurgery
1
Nivolumab
1
Multiparametric Magnetic Resonance Imaging
1
Microscopy
1
Immunonutrition Diet
1
Immune Checkpoint Inhibitors
1
Gemcitabine
1
Cystoscopy
1
Cisplatin
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Urinary Bladder Diseases
×
Multiparametric Magnetic Resonance Imaging
×
Clear all
NCT04442724
2025-08-14
FMBRT
Cedars-Sinai Medical Center
Phase NA
Recruiting
60 enrolled